Insider Buying Signals: AIM ImmunoTech Director Buys Shares Amid Falling Stock, Hinting at Confidence in Future Pipeline
Insider buying signals at AIM ImmunoTech: owner David Chemerow purchases shares below 1.23 USD, hinting confidence amid a steep decline and upcoming rights offering.
3 minutes to read